EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Enzymatically Crosslinked Collagen as a Versatile Matrix for In Vitro and In Vivo Co‐Engineering of Blood and Lymphatic Vasculature

Dominic Rütsche iD, Monica Nanni iD, Simon Rüdisser iD, Thomas Biedermann iD, Marcy Zenobi-Wong iD

Advanced Materials · 2023

DOI: 10.1002/adma.202209476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Dominic Rütsche und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Engineering + Biofabrication Laboratory, Department of Health Sciences & Technology, ETH Zurich, Otto-Stern-Weg 7, Zurich, 8093, Switzerland. Hauptthemen laut MEDLINE: Endothelial Cells, Factor XIII. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss National Science Foundation, Gemeinnützige Stiftung Accentus, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adequate vascularization is required for the successful translation of many in vitro engineered tissues. This study presents a novel collagen derivative that harbors multiple recognition peptides for orthogonal enzymatic crosslinking based on sortase A (SrtA) and Factor XIII (FXIII). SrtA‐mediated crosslinking enables the rapid co‐engineering of human blood and lymphatic microcapillaries and mesoscale capillaries in bulk hydrogels. Whereas tuning of gel stiffness determines the extent of neovascularization, the relative number of blood and lymphatic capillaries recapitulates the ratio of blood and lymphatic endothelial cells originally seeded into the hydrogel. Bioengineered capillaries readily form luminal structures and exhibit typical maturation markers both in vitro and in vivo. The secondary crosslinking enzyme Factor XIII is used for in situ tethering of the VEGF mimetic QK peptide to collagen. This approach supports the formation of blood and lymphatic capillaries in the absence of exogenous VEGF. Orthogonal enzymatic crosslinking is further used to bioengineer hydrogels with spatially defined polymer compositions with pro‐ and anti‐angiogenic properties. Finally, macroporous scaffolds based on secondary crosslinking of microgels enable vascularization independent from supporting fibroblasts. Overall, this work demonstrates for the first time the co‐engineering of mature micro‐ and meso‐sized blood and lymphatic capillaries using a highly versatile collagen derivative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsFactor XIIIHumansVascular Endothelial Growth Factor ACollagenTissue EngineeringPeptidesHydrogelsNeovascularization, PhysiologicTissue Scaffolds

Stichwörter der Autor:innen

blood vasculaturecollagenlymphatic vasculaturetissue engineeringvascularization

Substanzen

Factor XIIIVascular Endothelial Growth Factor ACollagenPeptidesHydrogels

Autor:innen und Institutionen

  • Tissue Engineering + Biofabrication Laboratory, Department of Health Sciences & Technology, ETH Zurich, Otto-Stern-Weg 7, Zurich, 8093, Switzerland.
  • Tissue Biology Research Unit, Department of Surgery, University Children's Hospital Zurich, Wagistrasse 12, Schlieren, 8952, Switzerland.
  • Institute for Mechanical Systems, Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, Zurich, 8092, Switzerland.
  • Biomolecular NMR Spectroscopy Platform, Department of Biology, ETH Zurich, Hönggerbergring 64, Zurich, 8093, Switzerland.

ORCID-Profile: Dominic Rütsche, Monica Nanni, Simon Rüdisser, Thomas Biedermann, Marcy Zenobi-Wong

Förderung

  • Swiss National Science Foundation
  • Gemeinnützige Stiftung Accentus
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Rütsche, D., Nanni, M., Rüdisser, S., Biedermann, T., & Zenobi-Wong, M. (2023). Enzymatically Crosslinked Collagen as a Versatile Matrix for In Vitro and In Vivo Co‐Engineering of Blood and Lymphatic Vasculature. Advanced Materials. https://doi.org/10.1002/adma.202209476

Vancouver

Rütsche D, Nanni M, Rüdisser S, Biedermann T, Zenobi-Wong M. Enzymatically Crosslinked Collagen as a Versatile Matrix for In Vitro and In Vivo Co‐Engineering of Blood and Lymphatic Vasculature. Advanced Materials. 2023. doi:10.1002/adma.202209476

BibTeX
@article{Rtsche2023,
  author = {Rütsche, Dominic and Nanni, Monica and Rüdisser, Simon and Biedermann, Thomas and Zenobi-Wong, Marcy},
  title = {Enzymatically Crosslinked Collagen as a Versatile Matrix for In Vitro and In Vivo Co‐Engineering of Blood and Lymphatic Vasculature},
  journal = {Advanced Materials},
  year = {2023},
  doi = {10.1002/adma.202209476}
}
Kostenlos starten →